Equities

DLH Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

DLH Holdings Corp

Actions
  • Price (EUR)4.60
  • Today's Change-0.24 / -4.96%
  • Shares traded205.00
  • 1 Year change-23.33%
  • Beta1.6061
Data delayed at least 15 minutes, as of Feb 11 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

  • Revenue in USD (TTM)322.61m
  • Net income in USD-1.08m
  • Incorporated1969
  • Employees2.30k
  • Location
    DLH Holdings Corp3565 Piedmont RoadNe, Building 3, Suite 700ATLANTA 30305United StatesUSA
  • Phone+1 (866) 952-1647
  • Websitehttps://www.dlhcorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.